234 related articles for article (PubMed ID: 6327874)
1. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.
Scala G; Kuang YD; Hall RE; Muchmore AV; Oppenheim JJ
J Exp Med; 1984 Jun; 159(6):1637-52. PubMed ID: 6327874
[TBL] [Abstract][Full Text] [Related]
2. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
[TBL] [Abstract][Full Text] [Related]
3. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes.
Kawano M; Matsushima K; Masuda A; Oppenheim JJ
Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895
[TBL] [Abstract][Full Text] [Related]
4. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.
Scala G; Morrone G; Tamburrini M; Alfinito F; Pastore CI; D'Alessio G; Venuta S
J Immunol; 1987 Apr; 138(8):2527-34. PubMed ID: 2435800
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
Wakasugi H; Rimsky L; Mahe Y; Kamel AM; Fradelizi D; Tursz T; Bertoglio J
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):804-8. PubMed ID: 3027706
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus].
Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA
Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049
[TBL] [Abstract][Full Text] [Related]
7. B-cell-derived interleukin-1 (IL-1)-like factor. II. Sources, effects, and biochemical properties.
Matsushima K; Tosato G; Benjamin D; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):418-26. PubMed ID: 2992809
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
9. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1.
Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH
Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
11. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of IL-2-induced T cell proliferation by a novel factor(s) present in murine spleen dendritic cell-T cell culture supernatants.
Everson MP; Spalding DM; Koopman WJ
J Immunol; 1989 Feb; 142(4):1183-94. PubMed ID: 2644351
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
14. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1-like activity produced by hybrids constructed with Epstein-Barr-virus-transformed human B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Pacciardi A; Tarantino E
Int Arch Allergy Appl Immunol; 1988; 85(1):76-81. PubMed ID: 2828240
[TBL] [Abstract][Full Text] [Related]
16. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
Booth RJ; Prestidge RL; Watson JD
J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
[TBL] [Abstract][Full Text] [Related]
17. Production of interleukin 1 activity by normal human peripheral blood B lymphocytes.
Matsushima K; Procopio A; Abe H; Scala G; Ortaldo JR; Oppenheim JJ
J Immunol; 1985 Aug; 135(2):1132-6. PubMed ID: 3874231
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulating activity in supernatants from EBV immortalized lymphocytes.
Blazar BA; Sutton LM; Strome M
Cancer Immunol Immunother; 1986; 22(1):62-7. PubMed ID: 3011263
[TBL] [Abstract][Full Text] [Related]
19. Accessory function of human tumor cell lines. I. Production of interleukin 1 by the human histiocytic lymphoma cell line U-937.
Palacios R; Ivhed I; Sideras P; Nilsson K; Sugawara I; Fernandez C
Eur J Immunol; 1982 Oct; 12(10):895-9. PubMed ID: 6756939
[TBL] [Abstract][Full Text] [Related]
20. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
